A lawsuit filed April 25 against AbbVie alleges the company engaged in a “fraudulent scheme” to hike prices by 470 percent of its most profitable drug, Humira.
Read the full post on Becker's Hospital Review - Healthcare News
AbbVie lawsuit claims 'unfair pricing' of Humira
